RBC Bioscience

RBC Bioscience Rule of 40

The Rule of 40 of RBC Bioscience (6848.TWO) as of Oct 13, 2026 is 36.45 %. In the previous year, Rule of 40 was 7.61 % — a change of 378.87% (higher).

Rule of 40

36.45 %

YoY

378.87%

Last updated:

Rule of 40 of RBC Bioscience is 2024 36.45 % . Rule of 40 of RBC Bioscience was 2023 7.61 % . It decreases by 378.87% higher compared to the previous year.

The RBC Bioscience Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2019
40.36 TWD
Jan 1, 2020
288.50 TWD
Jan 1, 2021
-36.98 TWD
Jan 1, 2022
-26.31 TWD
Jan 1, 2023
7.61 TWD
Jan 1, 2024
36.45 TWD
The RBC Bioscience Rule of 40 history
YEARRule of 40YoY
36.45 %+378.87%
7.61 %-128.92%
-26.31 %-28.83%
-36.98 %-112.82%
288.50 %+614.77%
40.36 %—
Access this data via the Eulerpool API
Get Free API Key

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Rule of 40 of RBC Bioscience is 36.45 % in 2024.

On Eulerpool you can find the complete historical development of Rule of 40 RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API
Get Free API Key

Quality — RBC Bioscience

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — RBC Bioscience